Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00091806
Recruitment Status : Completed
First Posted : September 21, 2004
Last Update Posted : July 10, 2009
Information provided by: